BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36224555)

  • 21. Accelerated failure time models for semi-competing risks data in the presence of complex censoring.
    Lee KH; Rondeau V; Haneuse S
    Biometrics; 2017 Dec; 73(4):1401-1412. PubMed ID: 28395116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study.
    Backes Y; Elias SG; Bhoelan BS; Groen JN; van Bergeijk J; Seerden TCJ; Pullens HJM; Spanier BWM; Geesing JMJ; Kessels K; Kerkhof M; Siersema PD; de Vos Tot Nederveen Cappel WH; van Lelyveld N; Wolfhagen FHJ; Ter Borg F; Offerhaus GJA; Lacle MM; Moons LMG;
    BMC Med; 2017 Jul; 15(1):129. PubMed ID: 28705200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing Importance of Biomarkers: a Bayesian Joint Modeling Approach of Longitudinal and Survival Data with Semicompeting Risks.
    Zhang F; Chen MH; Cong XJ; Chen Q
    Stat Modelling; 2021 Feb; 21(1-2):30-55. PubMed ID: 34326706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).
    Wang Z; Wang Y; Yang Y; Luo Y; Liu J; Xu Y; Liu X
    World J Surg Oncol; 2020 Feb; 18(1):30. PubMed ID: 32019568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection.
    Kim C; Kim WR; Kim KY; Chon HJ; Beom SH; Kim H; Jung M; Shin SJ; Kim NK; Ahn JB
    Clin Colorectal Cancer; 2018 Sep; 17(3):e513-e518. PubMed ID: 29661621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors related to mortality due to progression of disease in patients with colon cancer in the presence of competing risks: a retrospective cohort study in the west of Iran.
    Roshanaei G; Safari M; Faradmal J; Abbasi M; Khazaei S
    Gastroenterol Hepatol Bed Bench; 2021; 14(3):200-205. PubMed ID: 34221258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating disease incidence rates and transition probabilities in elderly patients using multi-state models: a case study in fragility fracture using a Bayesian approach.
    Llopis-Cardona F; Armero C; Sanfélix-Gimeno G
    BMC Med Res Methodol; 2023 Feb; 23(1):40. PubMed ID: 36788479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing survival time of outpatients with cervical cancer: at the university of Gondar referral hospital using the Bayesian approach.
    Gashu C; Tasfa B; Alemu C; Kassa Y
    BMC Womens Health; 2023 Feb; 23(1):59. PubMed ID: 36765315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal Cancer Incidence, Inequalities, and Prevention Priorities in Urban Texas: Surveillance Study With the "surveil" Software Package.
    Donegan C; Hughes AE; Lee SJC
    JMIR Public Health Surveill; 2022 Aug; 8(8):e34589. PubMed ID: 35972778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence, death risk, and related factors in patients with stage 0 colorectal cancer: A nationwide population-based study.
    Hsieh MH; Kung PT; Kuo WY; Ke TW; Tsai WC
    Medicine (Baltimore); 2020 Sep; 99(36):e21688. PubMed ID: 32899000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term Recurrence-free Survival After Standard Endoscopic Resection Versus Surgical Resection of Submucosal Invasive Colorectal Cancer: A Population-based Study.
    Belderbos TD; van Erning FN; de Hingh IH; van Oijen MG; Lemmens VE; Siersema PD
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):403-411.e1. PubMed ID: 27609703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of postoperative mortality, morbidity, and long-term survival after palliative resection in patients with colorectal cancer.
    Stillwell AP; Buettner PG; Siu SK; Stitz RW; Stevenson AR; Ho YH
    Dis Colon Rectum; 2011 May; 54(5):535-44. PubMed ID: 21471753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apical Node Involvement Does Not Influence Prognosis After Potentially Curative Resection for Stage III Colorectal Cancer: A Competing Risks Analysis.
    Ng KS; Dent OF; Chan C; Newland RC; Keshava A; Stewart P; Rickard MJFX; Chapuis PH
    Ann Surg; 2022 Jul; 276(1):e24-e31. PubMed ID: 33074895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hierarchical models for semi-competing risks data with application to quality of end-of-life care for pancreatic cancer.
    Lee KH; Dominici F; Schrag D; Haneuse S
    J Am Stat Assoc; 2016; 111(515):1075-1095. PubMed ID: 28303074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian Model Assessment in Joint Modeling of Longitudinal and Survival Data with Applications to Cancer Clinical Trials.
    Zhang D; Chen MH; Ibrahim JG; Boye ME; Shen W
    J Comput Graph Stat; 2017; 26(1):121-133. PubMed ID: 28239247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
    Robertson L; Yeoh SE; Broderick C; Stansby G; Agarwal R
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010837. PubMed ID: 30407621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer.
    Tham C; Chew M; Soong R; Lim J; Ang M; Tang C; Zhao Y; Ong SY; Liu Y
    Cancer; 2014 Oct; 120(20):3131-41. PubMed ID: 24925595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative Outcomes of Screen-Detected vs Non-Screen-Detected Colorectal Cancer in the Netherlands.
    de Neree Tot Babberich MPM; Vermeer NCA; Wouters MWJM; van Grevenstein WMU; Peeters KCMJ; Dekker E; Tanis PJ;
    JAMA Surg; 2018 Dec; 153(12):e183567. PubMed ID: 30285063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with risk for colorectal cancer recurrence after endoscopic resection of T1 tumors.
    Yoshii S; Nojima M; Nosho K; Omori S; Kusumi T; Okuda H; Tsukagoshi H; Fujita M; Yamamoto H; Hosokawa M
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):292-302.e3. PubMed ID: 23962552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).
    Ma Q; Liu D; Guo Y; Shi B; Song Z; Tian Y
    Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):342-8. PubMed ID: 20677562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.